iScience · 2022 · 30 citations · 50 references
Life SciencesMicrobiologyPathobiologyImmunopathologyInflammationInnate ImmunityFibrosisGut MicrobiomeGut MicrobiotaMicrobiome DysbiosisMicrobiome FunctionSystemic SclerosisCardiovascular BiologyEndothelial Progenitor CellsFlavin-containing Monooxygenase MetabolismFlavin-containing Monooxygenase PathwaysGut Microbiome AlterationsGut Microbiome DysbiosisMicrobiome-associated MetabolitesStromal Cell Activation
Intestinal dysbiosis is prominent in systemic sclerosis (SSc), but it remains unknown how it contributes to microvascular injury and fibrosis that are hallmarks of this disease. Trimethylamine (TMA) is generated by the gut microbiome and in the host converted by flavin-containing monooxygenase (FMO3) into trimethylamine N-oxide (TMAO), which has been implicated in chronic cardiovascular and metabolic diseases. Using cell culture systems and patient biopsies, we now show that TMAO reprograms skin fibroblasts, vascular endothelial cells, and adipocytic progenitor cells into myofibroblasts via the putative TMAO receptor protein R-like endoplasmic reticulum kinase (PERK). Remarkably, FMO3 was detected in skin fibroblasts and its expression stimulated by TGF-β1. Moreover, FMO3 was elevated in SSc skin biopsies and in SSc fibroblasts. A meta-organismal pathway thus might in SSc link gut microbiome to vascular remodeling and fibrosis via stromal cell reprogramming, implicating the FMO3-TMAO-PERK axis in pathogenesis, and as a promising target for therapy.
50
HTSeq—a Python framework to work with high-throughput sequencing data
Simon Anders, Paul Theodor Pyl, Wolfgang Huber · Bioinformatics · 2014 · 22.7K citations · Full text
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang, Elizabeth Klipfell, Brian J. Bennett et al. · Nature · 2011 · 5.6K citations